DDIs between corticosteroids and cobicistat or ritonavir

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1766卷 / 1期
关键词：
D O I：
10.1007/s40278-019-66078-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [21] Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro
    Roberts, Owain
    Khoo, Saye
    Owen, Andrew
    Siccardi, Marco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [22] Cushing's syndrome related to interaction between ritonavir or cobicistat and corticosteroid: a case control study in the french pharmacovigilance database
    Fedrizzi, Sophie
    Besnier, P.
    Demessine, L.
    Biour, M.
    Hilaire-Buys, D.
    de Canecaude, C.
    Fedrizzi, S.
    Parienti, J. -J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S13 - S13
  • [23] IN-VITRO EVALUATION OF DDI WITH COBICISTAT AND RITONAVIR USING HEPARG CELL LINE
    Storelli, E.
    Bruggmann, C.
    Doffey-Lazeyras, F.
    Samer, C.
    Desmeules, J.
    Daali, Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E98 - E98
  • [24] Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV
    Cattaneo, Dario
    Cossu, Maria Vittoria
    Rizzardini, Giuliano
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 927 - 935
  • [25] Management of Antiretroviral Therapy with Boosted Protease Inhibitors - Darunavir/Ritonavir or Darunavir/Cobicistat
    Marin, Ruxandra-Cristina
    Behl, Tapan
    Negrut, Nicoleta
    Bungau, Simona
    BIOMEDICINES, 2021, 9 (03)
  • [26] Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference
    Gervasoni, Cristina
    Riva, Agostino
    Cozzi, Valeria
    Capetti, Amedeo
    Rizzardini, Giuliano
    Clementi, Emilio
    Cattaneo, Dario
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (06) : 1842 - 1844
  • [27] Safety pro fi le of nirmatrelvir-ritonavir: Evidence of adverse events due to DDIs
    Gonzalez-Gomez, Alvaro
    Caro-Teller, Jose Manuel
    Gonzalez-Barrios, Ivan
    Castro-Frontinan, Almudena
    Rodriguez-Quesada, Pedro Pablo
    Ferrari-Piquero, Jose Miguel
    FARMACIA HOSPITALARIA, 2024, 48 (02) : T70 - T74
  • [28] SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir
    Celik, Ismail
    Gulten, Ezgi
    Onay-Besikci, Arzu
    Cinar, Gule
    Akdemir-Kalkan, Irem
    Kilcigil, Gulgun
    Memikoglu, K. Osman
    Birengel, M. Serhat
    Azap, Alpay
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 185 - 191
  • [29] Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults
    Sandy Van Hemelryck
    Erika Van Landuyt
    Jay Ariyawansa
    Martyn Palmer
    Martine J. C. Kothe
    Caroline Pollefliet
    AAPS Open, 10 (1)
  • [30] Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults
    Van Hemelryck, S.
    Van Landuyt, E.
    Ariyawansa, J.
    Palmer, M.
    Kothe, M.
    Pollefliet, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 189 - 190
12345